Key terms
About DRIO
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. DarioHealth serves customers globally. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest DRIO news
Apr 05
4:44pm ET
DarioHealth Raises CFO Zvi Ben-David’s Salary and Bonus Potential
Apr 01
8:40am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA), DarioHealth (DRIO) and Accelerate Diagnostics (AXDX)
Mar 07
7:20am ET
Analysts Are Bullish on Top Healthcare Stocks: DarioHealth (DRIO), United Therapeutics (UTHR)
Feb 23
7:06am ET
DarioHealth price target raised to $5.50 from $2.50 at Alliance Global Partners
Feb 22
4:33pm ET
DarioHealth Corp Unveils Updated Investor Presentation
Feb 22
8:10am ET
Analysts Offer Insights on Healthcare Companies: Outset Medical (OM), Exact Sciences (EXAS) and DarioHealth (DRIO)
Feb 21
7:45am ET
DarioHealth Corp Welcomes New COO, Eyes Strategic Expansion
Feb 21
6:17am ET
DarioHealth prices $22.4M private placement
Feb 21
6:12am ET
DarioHealth acquires Twill for $10M in cash, 10M in shares
Jan 11
8:35am ET
DarioHealth announces new contract to provide its cardiometabolic solution
No recent press releases are available for DRIO
DRIO Financials
Key terms
Ad Feedback
DRIO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
DRIO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
